Global Medical REIT, Inc. (GMRE)

Over the past six months, GMRE experienced several stock-related events. The company lowered its quarterly dividend from $0.21 to $0.15 per share in Q2 2025. A one-for-five reverse stock split was completed on September 19, 2025. The company announced an amendment and restatement of its credit facility on October 8, 2025. A public offering of 8.00% Series B Preferred Stock was proposed and priced in November 2025. Q2 2025 earnings were announced on August 5, 2025, and Q3 2025 financial results were announced on November 4, 2025, with an EPS of $1.12, beating estimates, though quarterly revenue of $37.23 million was below expectations. A $50 million common stock repurchase program was approved on August 13, 2025. There have been notable insider purchases in June and August 2025. Occupancy stood at 94.5% as of June 30, 2025. The share price as of November 21, 2025, was $32.11, a 27.52% decline from November 25, 2024.

Based on the available information, there is no explicit mention or indication of significant demand seasonality for Global Medical REIT, Inc.'s products and services. Demand for its properties is primarily driven by the ongoing need for healthcare services, which tends to be relatively stable throughout the year.

Global Medical REIT, Inc. (GMRE) is an internally managed real estate investment trust (REIT) focused on acquiring and leasing healthcare facilities across the United States. The company operates within the Real Estate sector, specifically in the Specialized REITs and Health Care REITs industries. GMRE acquires licensed healthcare facilities and leases them to healthcare providers, generating revenue through long-term leases. As of September 2025, GMRE owned 191 buildings with 315 tenants and 5.2 million leasable square feet.

Global Medical REIT, Inc. primarily operates across the United States, with properties in states including Texas, Florida, Ohio, Oklahoma, Pennsylvania, Arizona, and Illinois. The company strategically focuses on properties in secondary markets and suburbs of primary markets.

Global Medical REIT, Inc. aims to provide attractive returns to stockholders and support the healthcare industry. The company has a stated mission to deliver predictable distributions and long-term capital appreciation and has a reputation as a great counterpart in the market for healthcare facilities. The dividend reduction in Q2 2025 could be perceived negatively, while the stock repurchase program and insider buying could be seen as positive signals.

Global Medical REIT, Inc. has a diverse ownership structure, including institutional, insider, and retail investors. Institutions hold a significant portion of shares, with major holders including Vanguard Group Inc. and BlackRock, Inc. Insiders own a notable percentage of the company's stock, with Yanping Huang being the largest individual shareholder. Retail investors also hold a portion of the stock.